SPSC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. The stock is in a clear bearish trend (MACD negative and worsening; SMA200>SMA20>SMA5) and there are no Intellectia “strong buy” signals today to justify stepping in aggressively. While activist pressure creates upside optionality (including a potential sale process), the tape remains weak and the setup looks more like a fragile bounce attempt than a reliable entry.
Trend: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), confirming sustained downside momentum.
Momentum: MACD histogram at -0.472 and negatively expanding implies selling pressure is still building.
RSI: RSI_6 at 32.652 is near oversold (not a confirmed reversal signal yet), suggesting the stock can bounce but is not showing a clear trend change.
Levels: Pivot 91.14 is overhead; price (89.29 post-market) is below pivot, keeping near-term bias negative. Support S1 87.255 then S2 84.855. Resistance R1 95.025 then R2 97.425.
Pattern-based projection: Similar-pattern stats imply only modest expected upside over the next week (3.17%) and minimal next-month edge (0.89%), which is not compelling against a strong downtrend.
Intellectia Proprietary Trading Signals
on 2026-02-10 after hours (Est. EPS 0.
could act as a catalyst if guidance stabilizes or re-accelerates.
Price/technical damage: Shares are down over 50% in the past year per news summary; current indicators still show a downtrend with weakening momentum.
Fundamental/macro overhang: Morgan Stanley cited macro pressure in the retail end market constraining near-term growth and limited positive catalysts—risk of a continued range-bound or weak tape.
Binary outcomes from activism: If no sale process emerges or board pushback delays change, the stock can remain under pressure; activism alone does not guarantee a near-term bid.
Latest quarter provided: 2025/Q3. Revenue: $189.9M, +16.02% YoY (solid top-line growth). Net income: $25.57M, +8.99% YoY (growth but slower than revenue). EPS: $0.67, +8.06% YoY (positive, but not accelerating). Gross margin: 64.5%, ~flat to slightly down (-0.02% YoY), suggesting limited margin expansion. Overall: fundamentals are growing, but profitability growth is lagging revenue and the market is not rewarding it given macro/near-term growth concerns.
Recent analyst change: On 2025-11-11, Morgan Stanley downgraded SPSC to Equal Weight from Overweight and cut the price target to $100 from $140, citing constrained near-term growth, macro pressure on retail customers, and lack of catalysts (expecting the stock to be range-bound). Wall Street pros vs cons (from provided data): Pros: Still sees $100 PT (above the current ~$89), implying some upside if conditions stabilize. Cons: Explicitly calls out limited near-term catalysts and macro-driven demand headwinds, aligning with the current bearish technical trend. Influential/insider/political activity: Hedge funds neutral; insiders neutral; no recent Congress trading data available.
